Mahsa serves as CEO of Zippin Bio, where she leads the company’s overall vision and strategic direction. With deep expertise in oligonucleotide and peptide therapeutics, she drives scientific innovation while aligning research, development, and business objectives. She is experienced in chemical modification and targeted delivery of complex molecules.